Studio Romeo, Corso Vittorio Emanuele II n. 18, 00186, Rome, Italy.
Aesthetic Plast Surg. 2019 Jun;43(3):663-672. doi: 10.1007/s00266-018-1296-6. Epub 2019 Jan 3.
Lately, it has become evident that eye physical aging is mainly due to depletion of the upper eyelid fat causing laxity and wrinkles of the eyelid skin, and new therapeutic strategies aimed at solving the volume loss have appeared in the literature. The aim of this study is to provide a clear classification of upper eyelid aging after 500 consecutive cases and to present a standardization of the therapeutic approach to be adopted when using hyaluronic acid (HA) as fillers or a surgical approach.
The upper eyelid aging process of a total of 500 patients was classified based on the measurement of the pre-tarsal skin show m and the pre-septal skin show N. A total of 382 patients were treated exclusively with HA injections in the upper eyelid, 45 patients both with blepharoplasty surgery and HA filling, whereas only 73 patients underwent blepharoplasty only.
Patient satisfaction and at least 1-year clinical follow-up were used to evaluate the results. Pre-treatment and post-treatment photographic assessment was considered as well. A total of 447 patients were women, whereas 53 were men. The correct ratio between m and N was restored in all cases.
HA filling can be used as either the only volumization procedure or together with blepharoplasty to restore upper eyelid volume loss. The correct strategy has to be selected on the basis of a clear classification. The upper eyelid filling approach is a safe, manageable, lasting and low-cost technique providing excellent results when the correct procedure is followed.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
最近,人们已经清楚地认识到,眼部的自然衰老主要是由于上眼睑脂肪的消耗,导致眼睑皮肤松弛和皱纹的形成,并且文献中出现了旨在解决体积损失的新治疗策略。本研究的目的是对 500 例连续病例的上眼睑衰老进行明确分类,并为使用透明质酸(HA)作为填充物或手术方法时采用的治疗方法提供标准化。
根据术前睑板前皮肤显露 m 和术前睑板前皮肤显露 N 的测量,对上眼睑老化过程进行分类。共有 382 例患者仅接受透明质酸注射治疗,45 例患者接受眼睑成形术联合透明质酸填充治疗,而仅 73 例患者接受眼睑成形术。
使用患者满意度和至少 1 年的临床随访来评估结果。同时还考虑了治疗前后的照片评估。共有 447 例患者为女性,53 例为男性。所有病例均恢复了 m 和 N 之间的正确比例。
HA 填充可作为唯一的容积增大程序,也可与眼睑成形术联合使用,以恢复上眼睑的体积损失。必须根据明确的分类选择正确的策略。在上眼睑填充方法是一种安全、可管理、持久且低成本的技术,当遵循正确的程序时,可获得出色的效果。
证据等级 IV:本杂志要求作者为每篇文章分配一个证据等级。有关这些循证医学评级的完整描述,请参考目录或在线作者指南 www.springer.com/00266 。